COMMODORE CAPITAL LP - ALPINE IMMUNE SCIENCES INC ownership

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
COMMODORE CAPITAL LP ownership history of ALPINE IMMUNE SCIENCES INC
ValueSharesWeighting
Q3 2023$15,171,250
+11.4%
1,325,0000.0%1.77%
+15.8%
Q2 2023$13,621,000
+33.2%
1,325,0000.0%1.53%
-1.7%
Q1 2023$10,229,000
+104931.3%
1,325,0000.0%1.56%
+6.1%
Q4 2022$9,739
-99.9%
1,325,0000.0%1.47%
-4.3%
Q3 2022$9,540,0001,325,0001.53%
Other shareholders
ALPINE IMMUNE SCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 2,571,450$17,640,0004.25%
BVF INC/IL 1,201,717$8,244,0000.92%
Orbimed Advisors 3,670,955$25,183,0000.39%
TIGER MANAGEMENT L.L.C. 137,728$945,0000.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 475,450$3,262,0000.12%
Hikari Power Ltd 122,972$844,0000.09%
ALPINE WOODS CAPITAL INVESTORS, LLC 15,000$103,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 35,750$245,0000.00%
DRW Securities, LLC 10,000$69,0000.00%
VICTORY CAPITAL MANAGEMENT INC 134,542$923,0000.00%
View complete list of ALPINE IMMUNE SCIENCES INC shareholders